美国泌尿外科协会非肌层浸润性膀胱癌指南依从性仍然较差:评估农村州不依从相关因素与生存
该研究基于1992至2009年SEER-Medicare数据库纳入847例高危非肌层浸润性膀胱癌(NMIBC)患者,评估美国泌尿外科协会(AUA)指南依从性及相关因素。总体依从率低于1%,仅学术医学中心治疗(OR 11.68,95%CI 7.07-19.29)和肿瘤分期Tis(OR 3.24,95%CI 1.86-5.63)与依从性升高相关,依从性与癌症特异性生存无关。
要点
- 总体AUA指南依从率低于1%,研究期间未见明显改善。
- 学术医学中心治疗(OR 11.68)和Tis期(OR 3.24)与依从性升高相关。
- 居住距离不影响依从性,依从性与癌症特异性生存无关。
核心结论
- 经尿道膀胱肿瘤电切术(TURBT)后NMIBC治疗指南依从性有所改善但在该农村州仍不理想,且与在学术癌症中心治疗高度相关,原因未能用这些数据完全解释。
研究设计与样本
- 研究纳入1992至2009年SEER-Medicare数据库中847例爱荷华州高危NMIBC患者,均生存2年且期间未接受膀胱切除术或放疗。
- 依从性按AUA指南评估,并与患者人口学、肿瘤及治疗机构变量比较;农村性影响用SEER邮政编码数据计算患者至最近泌尿外科诊所的旅行距离分析。
主要发现
- 总体AUA指南依从率低(<1%),研究期间未明显改善。
- 多变量模型中,仅学术医学中心治疗(OR 11.68,95%CI 7.07-19.29)和肿瘤分期Tis(OR 3.24,95%CI 1.86-5.63)增加依从的比值。
- 居住距离小于10英里的患者比大于30英里的患者接受更多膀胱镜检查,但距离不影响其他措施的依从性。
- 依从性与癌症特异性生存无关。
关键数值与推荐
- 总体AUA指南依从率<1%。
- 学术医学中心治疗OR 11.68(95%CI 7.07-19.29)。
- 肿瘤分期Tis OR 3.24(95%CI 1.86-5.63)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify factors associated with nonmuscle invasive bladder cancer (NMIBC) American Urological Association (AUA) guideline compliance in a rural state, to evaluate compliance rates over time, and to assess the impact of patient and provider rurality on delivery of NMIBC care. METHODS: We identified 847 Iowans in Surveillance, Epidemiology, and End Results-Medicare from 1992 to 2009 with high-grade NMIBC who survived 2 years and were not treated with cystectomy or radiation during this period. Compliance with AUA guidelines was assessed over time and compared to patient demographic, tumor, and treatment institution variables. Impact of rurality was analyzed using Surveillance, Epidemiology, and End Results ZIP code data travel distance of patient to nearest urologist practice location. RESULTS: Overall compliance with AUA guidelines was low (<1%), and did not markedly improve over the study period. In the multivariable model, only care at an academic medical center (OR 11.68, 95% CI 7.07-19.29) and tumor stage (Tis; OR 3.24, 95% CI 1.86-5.63) increased the odds of compliance. Patients living closer (<10 miles) to their urologists underwent more cystoscopies than patients living further (>30 miles) but distance did not affect compliance with other measures. Compliance was not associated with cancer-specific survival. CONCLUSION: Compliance with post-Transurethral Resection of Bladder Tumor (TURBT) NMIBC treatment guidelines has improved but remains suboptimal in our rural state, and is highly associated with treatment at an academic cancer center for reasons that could not be fully explained with these data.
引用
- Tobert CM, Nepple KG, McDowell BD, et al. Compliance With American Urological Association Guidelines for Nonmuscle Invasive Bladder Cancer Remains Poor: Assessing Factors Associated With Noncompliance and Survival in a Rural State. Urology. 2019. PMID: 31252002. doi:10.1016/j.urology.2019.06.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。